Patent search ap:("BASF AG") AND inv:"NUERRENBACH AXEL" Page 1

1.

发明授权
Substituted chrysanthemumates 失效
Title translation: 取代CHRYSANTHEMUMATES

公开(公告)号：US3673215A

公开(公告)日：1972-06-27

申请号：US3673215D

申请日：1969-08-14

Applicant: BASF AG

Inventor： VOLLRATH ROBERT , NUERRENBACH AXEL , ADOLPHI HEINRICH

IPC: A01N53/02 , A01N53/10 , C07C29/42 , C07D307/42 , C07D317/54 , C07D317/62 , C07D317/64 , C07D333/16 , C07D63/12 , A61K27/00 , C07C69/74

CPC classification number: C07D307/42 , C07C29/42 , C07D317/54 , C07D317/62 , C07D317/64 , C07D333/16 , C07C33/30 , C07C33/483 , C07C33/28

Abstract: New and valuable chrysanthemumates, particularly esters having triunsaturated alcohols, and a process for controlling pests with these esters.

Abstract translation: 新颖有价值的菊花，特别是具有三不饱和醇的酯，以及用这些酯控制害虫的方法。

2.

发明授权
Preparation of granular vitamin a esters 失效
Title translation: 颗粒维生素A的制备

公开(公告)号：US3682989A

公开(公告)日：1972-08-08

申请号：US3682989D

申请日：1970-04-24

Applicant: BASF AG

Inventor： REIF WERNER , NUERRENBACH AXEL , FREYSCHLAG HERWIG

IPC: A61K9/16 , C07C175/00

CPC classification number: A61K9/1688

Abstract: Process for the preparation of granular vitamin A esters by contacting the molten vitamin A esters with a cold organic liquid kept in motion.

Abstract translation: 通过使熔融的维生素A酯与保持运动的冷有机液体接触来制备颗粒状维生素A酯的方法。

3.

发明授权
Continuous production of axerophthol 失效
Title translation: 连续生产AXEROPHTHOL

公开(公告)号：US3681466A

公开(公告)日：1972-08-01

申请号：US3681466D

申请日：1969-09-23

Applicant: BASF AG

Inventor： POMMER HORST , SEID BERNHARD , NUERRENBACH AXEL , KLOTMANN GEORG , GRASSNER HANS

IPC: C07C29/00 , C07C33/00 , C07C403/00

CPC classification number: C07C403/08 , C07C2601/16

Abstract: Continuous production of axerophthol by reaction of axerophthyl acetate with a lower alcohol using guanidine as transesterification catalyst in two stages, alkyl acetate and some of the excess alcohol being distilled off in the first stage and the remainder of the alcohol being removed in the second stage by distillation with a hydrocarbon as entrainer.

Abstract translation: 通过使用胍作为酯交换催化剂在两个阶段中通过乙酸半酯与低级醇反应连续生产萜烯酚，在第一阶段中将乙酸烷基酯和一些过量的醇在第二阶段被蒸馏除去，其余的醇在第二阶段被除去用烃作为夹带剂进行蒸馏。

4.

发明授权
Process for the production of ylenals 失效
Title translation: 生产YLENALS的过程

公开(公告)号：US3449438A

公开(公告)日：1969-06-10

申请号：US3449438D

申请日：1964-11-19

Applicant: BASF AG

Inventor： FREYSCHLAG HERWIG , REIF WERNER , NUERRENBACH AXEL , SARNECKI WILHELM

IPC: A01N57/22 , C07F9/535 , C07F9/28

CPC classification number: C07F9/5352 , A01N57/22

5.

发明授权
Continuous production of vitamin a palmitate 失效
Title translation: 连续生产维生素A棕榈酸酯

公开(公告)号：US3627795A

公开(公告)日：1971-12-14

申请号：US3627795D

申请日：1970-03-16

Applicant: BASF AG

Inventor： POMMER HORST , NUERRENBACH AXEL , KLOTMANN GEORG , GRASSNER HANS

IPC: C07C69/74 , C07C403/00 , C07C175/00

CPC classification number: C07C403/12 , C07C2601/16

Abstract: Vitamin A palmitate is prepared from vitamin A alcohol and palmitoyl chloride in the presence of a tertiary amine in a continuous process in which vitamin A palmitate is obtained in high purity and almost quantitative yields.

6.

发明授权
Process for producing acetals and hemiacetals of phosphonium salt compounds 失效
Title translation: 生产磷酸盐和磷酸盐化合物的方法

公开(公告)号：US3471569A

公开(公告)日：1969-10-07

申请号：US3471569D

申请日：1964-11-24

Applicant: BASF AG

Inventor： FREYSCHLAG HERWIG , REIF WERNER , NUERRENBACH AXEL , POMMER HORST

IPC: C07C45/72 , C07F9/54 , C07F9/02 , C07C41/00 , C07F9/28

CPC classification number: C07C403/14 , C07C45/72 , C07C2601/16 , C07F9/5407 , C07F9/5428 , C07C47/21

7.

发明专利
VINYLPHENOL DERIVATIVES, THEIR PREPARATION AND THEIR USE 未知

公开(公告)号：CA1338939C

公开(公告)日：1997-02-25

申请号：CA527819

申请日：1987-01-21

Applicant: BASF AG

Inventor： WUEST HANS-HEINER , JANSSEN BERND , FRICKEL FRITZ-FRIEDER , NUERRENBACH AXEL

IPC: A61K31/05 , A61K31/047 , A61K31/085 , A61K31/135 , A61K31/16 , A61K31/19 , A61K31/195 , A61K31/215 , A61K31/22 , A61K31/357 , A61K31/36 , A61P17/00 , A61P29/00 , A61P35/00 , C07C27/00 , C07C39/23 , C07C39/42 , C07C41/00 , C07C43/168 , C07C43/20 , C07C43/215 , C07C51/00 , C07C59/125 , C07C59/68 , C07C59/72 , C07C62/38 , C07C67/00 , C07C69/07 , C07C69/157 , C07C69/24 , C07C69/712 , C07C69/78 , C07C213/00 , C07C217/18 , C07D317/50 , C07D325/00

Abstract: Disclosed are new vinylphenol derivatives of the formula I where A is a methylene or ethylene radical which is unsubstituted or substituted by C1-C4-alkyl, R1 and R each hydrogen or methyl, R3 is hydrogen, C1-C4-alkyl, C1-C4-alkoxy or halogen, R4 is hydrogen, C1-C4-alkyl, cyclopropyl or cyclobutyl, R5 and R7 are each hydrogen or -OR8, where R8 is hydrogen, C1-C4-alkyl or C1-C4-alkanoyl, and R6 is hydrogen or is C1-C4-alkyl which is unsubstituted or substituted by carboxyl, C1-C4-alkoxycarbonyl, hydroxyl, C1-C4-alkoxy and/or amino or mono- or di-C1-C4-alkylamino, or is C1-C20-alkanoyl or is benzoyl which is unsubstituted or substituted as described for the C1-C4-alkyl group, or is aralkyl which is unsubstituted or similarly substituted in the aryl moiety, and R6 and R8 together may furthermore form a radical C=O, C=S, -CH2CH2- or CR9R10 , where R9 and R10 are each hydrogen, C1-C4-alkyl or phenyl, and their physiologically tolerated salts. These derivatives are for the treatment of various disorders of the skin, the mucous membranes and the internal organs, and of rheumatic disorder.